An Analysis of Patients with DNA Repair Pathway Mutations Treated with a PARP Inhibitor.
Borazanci E, Korn R, Liang WS, Guarnieri C, Haag S, Snyder C, Hendrickson K, Caldwell L, Von Hoff D, Jameson G.
Borazanci E, et al. Among authors: haag s.
Oncologist. 2020 Jan;25(1):e60-e67. doi: 10.1634/theoncologist.2018-0905. Epub 2019 Aug 7.
Oncologist. 2020.
PMID: 31391296
Free PMC article.